Lucid Diagnostics Inc. (LUCD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 111.12M |
| Enterprise Value | 102.24M |
| P/E Ratio | -1 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 14.1 |
| Price/Book Ratio | 12.93 |
| Enterprise/Revenue | 14.2 |
| Enterprise/EBITDA | -1.44 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -8.93 |
| Operating Margin | -9.42 |
| Return On Assets | -1.74 |
| Return On Equity | -6.11 |
| Revenue | 4.71M |
| Revenue/Share | 0.03 |
| Gross Profit | -2.84M |
| EBITDA | -57.12M |
| Net Income | -58.01M |
| Diluted EPS | -0.69 |
| Total Cash | 17.99M |
| Total Cash/Share | 0.09 |
| Total Debt | 18.49M |
| Total Debt/Equity | 3.12 |
| Current Ratio | 1.2 |
| Book Value Per Share | 0.03 |
| 52-Week Change | -63.82 |
| 52-Week High | 1.63 |
| 52-Week Low | 0.3 |
| Moving Average 50 Days | 0.62 |
| Moving Average 200 Days | 0.99 |
| Average Volume | 4.99M |
| Shares Outstanding | 190.95M |
| % Held by Institutions | 33.71 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |